Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $10.19 trillion, total revenue of $4.71 trillion and a weighted average PE ratio of 49.25.
Market Cap
10.19T
Revenue
4.71T
Profits
206.84B
PE Ratio
49.25
Profit Margin
4.39%
Dividend Yield
0.37%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 0.63% | 2,307,094 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 666.44B | 4.01% | 6,499,699 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 518.25B | 2.54% | 4,643,203 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 372.00B | 2.47% | 6,917,152 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 368.39B | 3.21% | 5,060,584 | 67.38B |
| 6 | NVS | Novartis AG | 312.69B | 3.32% | 1,276,312 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 301.49B | 2.94% | 2,837,430 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 261.70B | 1.14% | 1,651,448 | 47.35B |
| 9 | AMGN | Amgen Inc. | 260.58B | 4.50% | 3,075,005 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 217.26B | 4.59% | 5,955,477 | 30.99B |
| 11 | ABT | Abbott Laboratories | 200.27B | 5.80% | 8,150,496 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 199.09B | 5.32% | 20,268,793 | 50.70B |
| 13 | PFE | Pfizer Inc. | 175.24B | 2.48% | 33,029,169 | 63.63B |
| 14 | ISRG | Intuitive Surgical, Inc. | 168.04B | 9.98% | 3,452,850 | 11.58B |
| 15 | DHR | Danaher Corporation | 165.76B | 2.39% | 1,853,362 | 25.61B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.75B | 3.14% | 1,069,314 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 130.54B | 3.48% | 5,956,374 | 50.03B |
| 18 | SYK | Stryker Corporation | 130.34B | 10.25% | 4,279,085 | 26.30B |
| 19 | MDT | Medtronic plc | 129.04B | 6.60% | 8,566,861 | 37.54B |
| 20 | MCK | McKesson Corporation | 124.30B | 6.66% | 577,866 | 410.98B |
| 21 | SNY | Sanofi | 113.44B | 4.46% | 3,938,168 | 57.89B |
| 22 | HCA | HCA Healthcare, Inc. | 106.99B | 10.66% | 2,535,927 | 78.70B |
| 23 | GSK | GSK plc | 106.87B | 4.74% | 4,004,192 | 44.53B |
| 24 | CVS | CVS Health Corporation | 103.48B | -11.49% | 27,218,514 | 418.38B |
| 25 | MRNA | Moderna, Inc. | 99.49B | 9.09% | 10,483,126 | 2.23B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 94.61B | -3.14% | 857,008 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 94.47B | 5.68% | 950,997 | 201.83B |
| 28 | CI | The Cigna Group | 81.02B | 3.78% | 1,496,517 | 282.38B |
| 29 | COR | Cencora, Inc. | 67.42B | 3.76% | 1,884,258 | 337.40B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 67.33B | 1.37% | 2,505,835 | 29.86B |
| 31 | BSX | Boston Scientific Corporation | 66.61B | 5.66% | 24,261,652 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 60.08B | 2.58% | 1,219,177 | 254.25B |
| 33 | ARGX | argenx SE | 58.88B | 2.71% | 524,802 | 5.92B |
| 34 | EW | Edwards Lifesciences Corporation | 57.58B | 4.94% | 5,250,419 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 56.73B | 5.10% | 2,951,787 | 22.48B |
| 36 | NTRA | Natera, Inc. | 56.08B | 0.10% | 1,983,143 | 2.71B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 55.63B | 5.07% | 990,222 | 4.66B |
| 38 | MDLN | Medline Inc. | 52.82B | 17.85% | 18,276,989 | 30.68B |
| 39 | HUM | Humana Inc. | 50.97B | 1.57% | 1,215,321 | 145.68B |
| 40 | VEEV | Veeva Systems Inc. | 50.44B | 2.75% | 929,674 | 3.46B |
| 41 | A | Agilent Technologies, Inc. | 50.32B | 1.73% | 910,103 | 7.37B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 48.83B | -0.02% | 6,878,559 | 17.23B |
| 43 | WAT | Waters Corporation | 46.23B | 2.32% | 683,876 | 5.61B |
| 44 | IQV | IQVIA Holdings Inc. | 44.00B | 1.69% | 744,742 | 17.31B |
| 45 | ONC | BeOne Medicines AG | 43.21B | 7.05% | 491,879 | 6.13B |
| 46 | RVMD | Revolution Medicines, Inc. | 42.93B | 3.11% | 1,637,043 | - |
| 47 | HLN | Haleon plc | 41.83B | 4.47% | 22,962,903 | 14.80B |
| 48 | ALC | Alcon Inc. | 39.98B | 6.80% | 2,583,337 | 10.86B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 39.14B | 7.33% | 6,778,486 | 21.64B |
| 50 | RPRX | Royalty Pharma plc | 38.73B | 1.43% | 2,210,471 | 2.62B |
| 51 | CNC | Centene Corporation | 38.03B | 13.83% | 9,457,806 | 180.41B |
| 52 | BIIB | Biogen Inc. | 37.43B | 1.73% | 669,463 | 10.30B |
| 53 | ZTS | Zoetis Inc. | 36.22B | 5.63% | 5,471,771 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.74B | 2.10% | 134,499 | 4.13B |
| 55 | ILMN | Illumina, Inc. | 34.38B | -4.55% | 2,156,314 | 4.54B |
| 56 | RMD | ResMed Inc. | 33.78B | 5.76% | 1,269,100 | 5.73B |
| 57 | DXCM | DexCom, Inc. | 33.05B | 6.82% | 2,646,870 | 5.10B |
| 58 | PHG | Koninklijke Philips N.V. | 32.70B | 8.89% | 2,409,955 | 20.16B |
| 59 | GMAB | Genmab A/S | 31.71B | -1.23% | 3,200,079 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 29.92B | 4.13% | 430,760 | 14.59B |
| 61 | WST | West Pharmaceutical Services, Inc. | 28.44B | 0.32% | 676,295 | 3.40B |
| 62 | DGX | Quest Diagnostics Incorporated | 28.02B | 3.10% | 585,238 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 27.54B | 5.80% | 8,112,481 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 26.11B | 1.23% | 626,405 | 3.19B |
| 65 | INCY | Incyte Corporation | 25.09B | 4.69% | 1,281,221 | 6.01B |
| 66 | STE | STERIS plc | 24.20B | 7.30% | 888,489 | 6.04B |
| 67 | INSM | Insmed Incorporated | 23.75B | 3.67% | 1,421,199 | 1.52B |
| 68 | THC | Tenet Healthcare Corporation | 23.35B | 10.00% | 1,494,526 | 22.15B |
| 69 | GH | Guardant Health, Inc. | 23.05B | -1.83% | 1,416,585 | 1.18B |
| 70 | BNTX | BioNTech SE | 22.71B | 4.02% | 995,259 | 2.75B |
| 71 | VTRS | Viatris Inc. | 21.96B | 1.03% | 4,245,000 | 14.74B |
| 72 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.70B | 1.35% | 2,216,706 | 5.01B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 21.08B | 13.86% | 3,855,091 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.44B | -0.65% | 146,361 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 18.11B | -0.75% | 1,782,796 | 2.94B |
| 76 | EXEL | Exelixis, Inc. | 17.85B | 1.15% | 1,745,153 | 2.50B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.98B | 1.30% | 1,642,219 | 3.70B |
| 78 | ASND | Ascendis Pharma A/S | 16.87B | 2.68% | 364,882 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.92B | -5.22% | 1,187,310 | 3.98B |
| 80 | ICLR | ICON Public Limited Company | 15.30B | 0.25% | 842,707 | 8.23B |
| 81 | SOLV | Solventum Corporation | 15.29B | 5.96% | 1,022,754 | 8.31B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 15.07B | 1.08% | 512,519 | 4.72B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 15.04B | 4.32% | 3,825,770 | 945.54M |
| 84 | GKOS | Glaukos Corporation | 14.94B | 8.34% | 1,363,410 | 690.33M |
| 85 | HALO | Halozyme Therapeutics, Inc. | 14.85B | 1.73% | 1,037,044 | 1.66B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 14.61B | 0.40% | 1,853,377 | 15.25B |
| 87 | TEM | Tempus AI, Inc. | 13.89B | -1.93% | 4,830,392 | 1.51B |
| 88 | EHC | Encompass Health Corporation | 13.86B | 4.27% | 542,573 | 6.34B |
| 89 | BAX | Baxter International Inc. | 13.65B | 3.53% | 6,780,473 | 11.61B |
| 90 | SNN | Smith & Nephew plc | 13.56B | 8.04% | 2,272,161 | 6.30B |
| 91 | SMMT | Summit Therapeutics Inc. | 12.84B | 1.65% | 2,948,961 | - |
| 92 | PEN | Penumbra, Inc. | 12.73B | 0.94% | 259,867 | 1.56B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.64B | 2.93% | 4,352,565 | 5.02B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.41B | 2.83% | 1,225,823 | 3.44B |
| 95 | FMS | Fresenius Medical Care AG | 12.36B | 6.76% | 1,700,034 | 22.12B |
| 96 | COO | The Cooper Companies, Inc. | 12.24B | 5.79% | 2,115,728 | 4.24B |
| 97 | DVA | DaVita Inc. | 12.00B | 4.69% | 719,686 | 14.17B |
| 98 | MOH | Molina Healthcare, Inc. | 11.99B | 10.77% | 1,447,063 | 42.08B |
| 99 | ALGN | Align Technology, Inc. | 11.71B | 8.77% | 1,185,245 | 4.16B |
| 100 | GMED | Globus Medical, Inc. | 11.67B | 9.21% | 1,458,789 | 3.14B |
| 101 | KYMR | Kymera Therapeutics, Inc. | 11.55B | 6.47% | 1,016,528 | 102.24M |
| 102 | UHS | Universal Health Services, Inc. | 11.53B | 10.41% | 1,018,296 | 18.35B |
| 103 | RGEN | Repligen Corporation | 11.44B | 0.41% | 709,012 | 805.61M |
| 104 | TECH | Bio-Techne Corporation | 11.41B | 0.18% | 2,733,519 | 1.22B |
| 105 | PODD | Insulet Corporation | 11.28B | 5.02% | 1,580,959 | 3.05B |
| 106 | BMRN | BioMarin Pharmaceutical Inc. | 11.05B | 2.59% | 1,456,364 | 3.66B |
| 107 | OSCR | Oscar Health, Inc. | 11.00B | 10.12% | 10,604,720 | 15.32B |
| 108 | ENSG | The Ensign Group, Inc. | 10.86B | 3.04% | 272,018 | 5.67B |
| 109 | AVTR | Avantor, Inc. | 10.65B | 0.77% | 6,519,429 | 6.64B |
| 110 | QGEN | Qiagen N.V. | 10.50B | 0.81% | 2,080,180 | 2.10B |
| 111 | PCVX | Vaxcyte, Inc. | 10.23B | 6.89% | 1,282,643 | - |
| 112 | BIO | Bio-Rad Laboratories, Inc. | 10.11B | 0.90% | 133,267 | 2.59B |
| 113 | BRKR | Bruker Corporation | 9.81B | 13.93% | 6,104,359 | 3.51B |
| 114 | HSIC | Henry Schein, Inc. | 9.78B | 6.40% | 2,135,731 | 13.73B |
| 115 | HNGE | Hinge Health, Inc. | 9.77B | 3.67% | 1,467,920 | 800.82M |
| 116 | CAI | Caris Life Sciences, Inc. | 9.31B | 0.27% | 2,154,611 | 989.61M |
| 117 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.27B | 1.20% | 1,897,575 | 1.43B |
| 118 | ATR | AptarGroup, Inc. | 9.21B | 2.14% | 321,412 | 3.99B |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 9.21B | 1.51% | 281,235 | 281.99M |
| 120 | KRYS | Krystal Biotech, Inc. | 9.21B | 1.87% | 223,724 | 470.03M |
| 121 | IBRX | ImmunityBio, Inc. | 9.20B | 4.70% | 6,140,307 | 165.79M |
| 122 | SYRE | Spyre Therapeutics, Inc. | 9.09B | -1.96% | 931,627 | - |
| 123 | HQY | HealthEquity, Inc. | 9.00B | 6.60% | 1,003,571 | 1.36B |
| 124 | TWST | Twist Bioscience Corporation | 8.86B | 0.71% | 1,197,928 | 431.80M |
| 125 | CYTK | Cytokinetics, Incorporated | 8.86B | 2.25% | 1,462,216 | 67.67M |
| 126 | TGTX | TG Therapeutics, Inc. | 8.77B | 1.77% | 1,119,133 | 799.54M |
| 127 | TXG | 10x Genomics, Inc. | 8.73B | 2.63% | 1,864,653 | 616.91M |
| 128 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.71B | 3.59% | 864,246 | 669.50M |
| 129 | CORT | Corcept Therapeutics Incorporated | 8.40B | -5.18% | 1,582,637 | 963.65M |
| 130 | PACS | PACS Group, Inc. | 7.96B | 7.73% | 1,254,100 | 5.71B |
| 131 | PRAX | Praxis Precision Medicines, Inc. | 7.90B | 0.91% | 186,275 | 7.46M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.82B | 1.14% | 467,553 | 5.33M |
| 133 | ALKS | Alkermes plc | 7.71B | 0.61% | 1,049,201 | 1.75B |
| 134 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.53B | 2.70% | 596,851 | 945.96M |
| 135 | GRFS | Grifols, S.A. | 7.48B | -0.35% | 446,802 | 8.63B |
| 136 | BLCO | Bausch + Lomb Corporation | 7.35B | 2.60% | 767,259 | 5.42B |
| 137 | AXSM | Axsome Therapeutics, Inc. | 7.23B | -1.50% | 540,954 | 865.27M |
| 138 | CHE | Chemed Corporation | 7.10B | 2.68% | 103,585 | 2.66B |
| 139 | AMRX | Amneal Pharmaceuticals, Inc. | 6.96B | -1.14% | 2,338,804 | 3.20B |
| 140 | ORKA | Oruka Therapeutics, Inc. | 6.65B | 0.95% | 438,905 | - |
| 141 | IONS | Ionis Pharmaceuticals, Inc. | 6.65B | -0.99% | 1,892,568 | 874.09M |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.60B | 0.33% | 790,801 | 1.56B |
| 143 | GRAL | GRAIL, Inc. | 6.38B | 2.51% | 355,356 | 165.26M |
| 144 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.36B | 6.81% | 2,824,217 | 280.75M |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.34B | 1.15% | 106,133 | 253.83M |
| 146 | TFX | Teleflex Incorporated | 6.32B | 6.50% | 788,679 | 2.25B |
| 147 | HIMS | Hims & Hers Health, Inc. | 6.30B | 5.10% | 9,553,667 | 2.58B |
| 148 | RDNT | RadNet, Inc. | 6.30B | 9.39% | 1,210,903 | 2.27B |
| 149 | KOD | Kodiak Sciences Inc. | 6.24B | 0.62% | 622,841 | - |
| 150 | DOCS | Doximity, Inc. | 6.22B | 7.02% | 1,836,708 | 655.57M |
| 151 | BLTE | Belite Bio, Inc | 6.21B | 1.31% | 62,522 | - |
| 152 | MIRM | Mirum Pharmaceuticals, Inc. | 6.16B | 8.93% | 680,320 | 670.78M |
| 153 | IMVT | Immunovant, Inc. | 6.10B | 1.62% | 564,542 | - |
| 154 | CGON | CG Oncology, Inc. | 5.85B | 3.11% | 659,518 | 6.23M |
| 155 | HAE | Haemonetics Corporation | 5.78B | 5.61% | 515,700 | 1.35B |
| 156 | PTCT | PTC Therapeutics, Inc. | 5.75B | 0.95% | 748,149 | 1.16B |
| 157 | MANE | Veradermics, Incorporated | 5.65B | 1.26% | 381,310 | - |
| 158 | SRRK | Scholar Rock Holding Corporation | 5.65B | 5.46% | 914,976 | - |
| 159 | WAY | Waystar Holding Corp. | 5.60B | 5.55% | 2,562,239 | 1.26B |
| 160 | CON | Concentra Group Holdings Parent, Inc. | 5.54B | 8.16% | 1,756,982 | 2.29B |
| 161 | MMED | MiniMed Group, Inc. | 5.49B | 3.45% | 7,747,883 | 3.22B |
| 162 | LFST | LifeStance Health Group, Inc. | 5.45B | 6.73% | 2,083,792 | 1.58B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.44B | 7.83% | 867,056 | 1.61B |
| 164 | COGT | Cogent Biosciences, Inc. | 5.42B | 0.55% | 1,353,796 | - |
| 165 | BLLN | BillionToOne, Inc. | 5.36B | 2.79% | 385,043 | 397.41M |
| 166 | LIVN | LivaNova PLC | 5.24B | 18.99% | 2,869,233 | 1.51B |
| 167 | ERAS | Erasca, Inc. | 5.19B | 1.43% | 2,144,214 | - |
| 168 | CRSP | CRISPR Therapeutics AG | 5.02B | 3.84% | 926,103 | 25.17M |
| 169 | HTFL | HeartFlow, Inc. | 4.92B | 4.08% | 1,117,065 | 212.07M |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.86B | 4.35% | 1,963,931 | 651.03M |
| 171 | OPCH | Option Care Health, Inc. | 4.75B | -0.22% | 2,752,013 | 5.75B |
| 172 | DNTH | Dianthus Therapeutics, Inc. | 4.71B | 1.86% | 564,867 | 1.90M |
| 173 | SHC | Sotera Health Company | 4.71B | 2.87% | 2,962,126 | 1.23B |
| 174 | CDNA | CareDx, Inc. | 4.51B | -3.03% | 973,788 | 497.40M |
| 175 | LEGN | Legend Biotech Corporation | 4.46B | 7.12% | 2,120,144 | 1.27B |
| 176 | IRTC | iRhythm Holdings, Inc. | 4.45B | 6.86% | 858,708 | 825.34M |
| 177 | DFTX | Definium Therapeutics, Inc. | 4.37B | -2.66% | 994,392 | - |
| 178 | NVST | Envista Holdings Corporation | 4.34B | 9.06% | 3,542,549 | 2.86B |
| 179 | ICUI | ICU Medical, Inc. | 4.33B | 7.11% | 293,482 | 2.16B |
| 180 | ITGR | Integer Holdings Corporation | 4.31B | 0.13% | 388,631 | 1.83B |
| 181 | ADPT | Adaptive Biotechnologies Corporation | 4.28B | 3.88% | 1,494,524 | 308.08M |
| 182 | ARQT | Arcutis Biotherapeutics, Inc. | 4.27B | 6.09% | 1,214,350 | 463.98M |
| 183 | LQDA | Liquidia Corporation | 4.26B | 12.82% | 3,952,874 | 450.91M |
| 184 | VCYT | Veracyte, Inc. | 4.16B | 2.82% | 1,026,234 | 561.90M |
| 185 | EWTX | Edgewise Therapeutics, Inc. | 4.10B | 0.27% | 437,349 | - |
| 186 | PLSE | Pulse Biosciences, Inc. | 4.06B | 8.95% | 331,508 | 1.19M |
| 187 | IOVA | Iovance Biotherapeutics, Inc. | 3.98B | -0.57% | 11,904,766 | 324.97M |
| 188 | ABCL | AbCellera Biologics Inc. | 3.96B | 0.33% | 1,861,033 | 66.17M |
| 189 | RLAY | Relay Therapeutics, Inc. | 3.92B | 2.47% | 1,964,533 | 10.35M |
| 190 | TNGX | Tango Therapeutics, Inc. | 3.90B | -0.17% | 1,689,585 | 53.81M |
| 191 | XENE | Xenon Pharmaceuticals Inc. | 3.79B | 2.28% | 1,089,814 | 7.50M |
| 192 | PBLS | Parabilis Medicines, Inc. | 3.74B | 3.38% | 560,165 | 148.00K |
| 193 | IRON | Disc Medicine, Inc. | 3.68B | 2.07% | 272,577 | - |
| 194 | ACAD | Acadia Pharmaceuticals Inc. | 3.67B | 3.65% | 3,233,122 | 1.14B |
| 195 | OGN | Organon & Co. | 3.64B | 0.04% | 1,258,975 | 6.10B |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.63B | -1.06% | 970,810 | -665.00K |
| 197 | VKTX | Viking Therapeutics, Inc. | 3.56B | 6.94% | 2,954,322 | - |
| 198 | STVN | Stevanato Group S.p.A. | 3.54B | -8.01% | 3,405,701 | 1.42B |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.44B | 1.94% | 2,730,954 | - |
| 200 | ELVN | Enliven Therapeutics, Inc. | 3.42B | 4.24% | 635,113 | - |
| 201 | CELC | Celcuity Inc. | 3.38B | -0.83% | 794,599 | - |
| 202 | TLX | Telix Pharmaceuticals Limited | 3.38B | 6.53% | 479,156 | 890.79M |
| 203 | NHC | National HealthCare Corporation | 3.33B | 3.22% | 160,706 | 1.56B |
| 204 | DNLI | Denali Therapeutics Inc. | 3.32B | 6.79% | 3,305,206 | 21.38M |
| 205 | SUPN | Supernus Pharmaceuticals, Inc. | 3.32B | -0.11% | 3,972,593 | 1.37B |
| 206 | ATRC | AtriCure, Inc. | 3.32B | 8.01% | 879,353 | 589.80M |
| 207 | VRDN | Viridian Therapeutics, Inc. | 3.21B | 12.56% | 8,549,362 | 26.31M |
| 208 | AVAH | Aveanna Healthcare Holdings Inc. | 3.13B | 8.06% | 1,186,395 | 2.60B |
| 209 | BHC | Bausch Health Companies Inc. | 3.13B | 2.70% | 2,561,818 | 11.11B |
| 210 | AXGN | Axogen, Inc. | 3.13B | 5.72% | 1,117,445 | 266.93M |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 3.06B | 1.13% | 741,416 | 36.54M |
| 212 | TARS | Tarsus Pharmaceuticals, Inc. | 3.04B | -4.72% | 1,510,420 | 682.20M |
| 213 | ACHC | Acadia Healthcare Company, Inc. | 3.02B | 9.66% | 3,273,609 | 3.37B |
| 214 | SGRY | Surgery Partners, Inc. | 3.02B | 0.50% | 7,363,532 | 3.37B |
| 215 | PRVA | Privia Health Group, Inc. | 2.90B | 5.78% | 1,752,724 | 2.36B |
| 216 | ZLAB | Zai Lab Limited | 2.81B | 3.23% | 576,173 | 449.61M |
| 217 | RGC | Regencell Bioscience Holdings Limited | 2.79B | -8.62% | 197,116 | - |
| 218 | RCUS | Arcus Biosciences, Inc. | 2.77B | 1.80% | 916,193 | 117.00M |
| 219 | BEAM | Beam Therapeutics Inc. | 2.76B | 4.86% | 775,233 | 146.64M |
| 220 | NEOG | Neogen Corporation | 2.74B | 3.64% | 2,264,920 | 884.00M |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.70B | 4.48% | 457,018 | 1.46B |
| 222 | WRBY | Warby Parker Inc. | 2.67B | -1.60% | 5,206,861 | 911.61M |
| 223 | BKD | Brookdale Senior Living Inc. | 2.66B | 7.23% | 3,528,127 | 2.93B |
| 224 | UFPT | UFP Technologies, Inc. | 2.58B | 18.69% | 306,654 | 649.52M |
| 225 | MBX | MBX Biosciences, Inc. | 2.58B | -2.71% | 237,051 | - |
| 226 | TMDX | TransMedics Group, Inc. | 2.55B | 9.30% | 1,022,133 | 668.47M |
| 227 | XNCR | Xencor, Inc. | 2.54B | 11.36% | 1,715,642 | 104.97M |
| 228 | CLOV | Clover Health Investments, Corp. | 2.53B | 10.96% | 5,350,668 | 2.48B |
| 229 | HCM | HUTCHMED (China) Limited | 2.52B | 5.96% | 89,957 | 549.12M |
| 230 | MD | Pediatrix Medical Group, Inc. | 2.52B | 7.88% | 640,555 | 1.96B |
| 231 | NAMS | NewAmsterdam Pharma Company N.V. | 2.49B | 4.72% | 1,430,079 | 25.94M |
| 232 | PBH | Prestige Consumer Healthcare Inc. | 2.49B | 6.00% | 403,029 | 1.10B |
| 233 | ADMA | ADMA Biologics, Inc. | 2.41B | -2.97% | 8,365,380 | 512.28M |
| 234 | PHVS | Pharvaris N.V. | 2.40B | -1.78% | 193,933 | - |
| 235 | ADUS | Addus HomeCare Corporation | 2.37B | 2.22% | 261,045 | 1.50B |
| 236 | PGNY | Progyny, Inc. | 2.33B | 4.61% | 694,421 | 1.31B |
| 237 | VCEL | Vericel Corporation | 2.33B | 10.84% | 1,117,683 | 306.30M |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.33B | -0.12% | 382,801 | 158.00K |
| 239 | PVLA | Palvella Therapeutics, Inc. | 2.33B | 5.58% | 255,785 | - |
| 240 | RXRX | Recursion Pharmaceuticals, Inc. | 2.32B | 5.43% | 17,215,833 | 68.23M |
| 241 | BHVN | Biohaven Ltd. | 2.31B | -2.24% | 899,613 | - |
| 242 | IMNM | Immunome, Inc. | 2.29B | -4.28% | 2,130,255 | 4.02M |
| 243 | VERA | Vera Therapeutics, Inc. | 2.29B | 3.58% | 1,302,021 | - |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.28B | 2.96% | 1,052,094 | 321.74M |
| 245 | PRGO | Perrigo Company plc | 2.24B | 2.74% | 3,521,963 | 4.09B |
| 246 | NEO | NeoGenomics, Inc. | 2.22B | 2.08% | 617,517 | 787.75M |
| 247 | ZYME | Zymeworks Inc. | 2.20B | 3.05% | 737,790 | 37.13M |
| 248 | SEPN | Septerna, Inc. | 2.20B | 7.73% | 438,767 | 98.88M |
| 249 | TRLV | Trulieve Cannabis Corp. | 2.18B | -2.08% | 1,687,026 | 1.14B |
| 250 | LKFT | Lakefront Biotherapeutics NV | 2.18B | 5.69% | 302,689 | 1.13B |
| 251 | SDGR | Schrödinger, Inc. | 2.13B | 4.53% | 1,043,768 | 259.04M |
| 252 | XRAY | DENTSPLY SIRONA Inc. | 2.10B | 8.12% | 4,994,672 | 3.64B |
| 253 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.08B | -4.96% | 3,705,077 | 961.51M |
| 254 | WGS | GeneDx Holdings Corp. | 2.07B | 1.17% | 289,556 | 454.43M |
| 255 | TRAX | First Tracks Biotherapeutics, Inc. | 2.05B | 5.51% | 576,320 | - |
| 256 | COAG | Hemab Therapeutics Holdings, Inc. | 2.05B | 2.00% | 312,563 | - |
| 257 | ASTH | Astrana Health, Inc. | 2.05B | 8.90% | 277,188 | 3.84B |
| 258 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.03B | 4.97% | 2,170,322 | 208.78M |
| 259 | LMAT | LeMaitre Vascular, Inc. | 2.02B | 9.57% | 308,939 | 262.43M |
| 260 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | -6.67% | 1,861,111 | 989.36M |
| 261 | FTRE | Fortrea Holdings Inc. | 2.01B | -0.57% | 805,257 | 2.67B |
| 262 | SRPT | Sarepta Therapeutics, Inc. | 2.01B | 2.43% | 779,282 | 1.97B |
| 263 | TRVI | Trevi Therapeutics, Inc. | 1.99B | 0.79% | 820,183 | - |
| 264 | ESTA | Establishment Labs Holdings Inc. | 1.97B | 7.63% | 240,065 | 264.03M |
| 265 | VIR | Vir Biotechnology, Inc. | 1.96B | 3.48% | 1,425,829 | 303.23M |
| 266 | REPL | Replimune Group, Inc. | 1.96B | -0.10% | 2,361,656 | - |
| 267 | INSP | Inspire Medical Systems, Inc. | 1.94B | 8.22% | 485,079 | 880.94M |
| 268 | XERS | Xeris Biopharma Holdings, Inc. | 1.93B | 2.27% | 1,893,964 | 335.41M |
| 269 | ALMR | Alamar Biosciences, Inc. | 1.90B | -9.45% | 956,762 | 114.05M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | 0.99% | 388,880 | 98.34M |
| 271 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 0.14% | 412,689 | 1.00M |
| 272 | AMN | AMN Healthcare Services, Inc. | 1.85B | 5.56% | 319,089 | 3.43B |
| 273 | KMTS | Kestra Medical Technologies, Ltd. | 1.84B | 6.65% | 841,871 | 106.73M |
| 274 | MESO | Mesoblast Limited | 1.84B | -3.11% | 247,129 | 120.25M |
| 275 | SLS | SELLAS Life Sciences Group, Inc. | 1.84B | 2.48% | 4,166,548 | - |
| 276 | ARDT | Ardent Health, Inc. | 1.83B | 10.93% | 759,877 | 6.41B |
| 277 | GENB | Generate Biomedicines, Inc. | 1.81B | 1.95% | 396,953 | 26.48M |
| 278 | BFLY | Butterfly Network, Inc. | 1.81B | 5.78% | 4,318,987 | 123.26M |
| 279 | OMCL | Omnicell, Inc. | 1.81B | 11.68% | 486,776 | 1.24B |
| 280 | PGEN | Precigen, Inc. | 1.80B | -4.10% | 7,223,873 | 85.72M |
| 281 | MAZE | Maze Therapeutics, Inc. | 1.80B | 3.44% | 291,059 | 20.00M |
| 282 | HCSG | Healthcare Services Group, Inc. | 1.79B | 3.95% | 387,074 | 1.88B |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.78B | 1.74% | 805,169 | 28.21M |
| 284 | TDOC | Teladoc Health, Inc. | 1.76B | 8.55% | 5,169,523 | 2.47B |
| 285 | ABSI | Absci Corporation | 1.76B | 2.50% | 3,125,830 | 1.56M |
| 286 | SNDA | Sonida Senior Living, Inc. | 1.75B | 8.73% | 382,689 | 481.07M |
| 287 | NRIX | Nurix Therapeutics, Inc. | 1.73B | -38.57% | 15,686,078 | 701.94M |
| 288 | NVAX | Novavax, Inc. | 1.72B | 8.01% | 4,384,418 | 413.80M |
| 289 | NTLA | Intellia Therapeutics, Inc. | 1.72B | 3.67% | 1,877,811 | 59.51M |
| 290 | AZTA | Azenta, Inc. | 1.72B | 5.71% | 543,535 | 613.81M |
| 291 | ALHC | Alignment Healthcare, Inc. | 1.71B | 10.69% | 3,289,117 | 4.94B |
| 292 | CERT | Certara, Inc. | 1.71B | 3.13% | 1,459,113 | 421.75M |
| 293 | NVCR | NovoCure Limited | 1.70B | 8.49% | 979,308 | 725.39M |
| 294 | ALVO | Alvotech | 1.69B | 4.30% | 394,668 | 494.61M |
| 295 | PSNL | Personalis, Inc. | 1.69B | 0.19% | 1,765,624 | 69.67M |
| 296 | RARE | Ultragenyx Pharmaceutical Inc. | 1.68B | 2.77% | 5,396,798 | 730.00M |
| 297 | ADRX | ADARx Pharmaceuticals, Inc. | 1.68B | -7.02% | 285,768 | 6.13M |
| 298 | BRVE | Braveheart Bio, Inc. | 1.64B | -6.03% | 510,000 | - |
| 299 | AGL | agilon health, inc. | 1.64B | 11.25% | 198,172 | 5.92B |
| 300 | KLRA | Kailera Therapeutics, Inc. | 1.64B | 0.32% | 307,193 | - |
| 301 | LYCA | Lycia Therapeutics, Inc. | 1.63B | 2.64% | 148,900 | 4.44M |
| 302 | NUVB | Nuvation Bio Inc. | 1.62B | -1.71% | 5,207,529 | 169.90M |
| 303 | QURE | uniQure N.V. | 1.60B | -3.48% | 1,986,205 | 20.17M |
| 304 | PAHC | Phibro Animal Health Corporation | 1.59B | 4.14% | 137,989 | 1.52B |
| 305 | CNMD | CONMED Corporation | 1.58B | 12.43% | 333,492 | 1.37B |
| 306 | OCUL | Ocular Therapeutix, Inc. | 1.56B | 3.96% | 2,512,938 | 52.06M |
| 307 | PNTG | The Pennant Group, Inc. | 1.54B | 7.00% | 175,106 | 1.10B |
| 308 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -0.73% | 149,154 | 978.38M |
| 309 | RAPP | Rapport Therapeutics, Inc. | 1.53B | 1.83% | 610,529 | 20.00M |
| 310 | INVA | Innoviva, Inc. | 1.53B | 1.22% | 476,510 | 440.00M |
| 311 | NBTX | Nanobiotix S.A. | 1.53B | 5.01% | 215,018 | 13.15M |
| 312 | IMCR | Immunocore Holdings plc | 1.50B | -2.96% | 433,306 | 430.78M |
| 313 | MLYS | Mineralys Therapeutics, Inc. | 1.48B | 4.50% | 1,274,561 | - |
| 314 | AAPG | Ascentage Pharma Group International | 1.48B | 11.13% | 18,796 | 94.61M |
| 315 | TYRA | Tyra Biosciences, Inc. | 1.47B | 0.09% | 352,437 | - |
| 316 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.11% | 1,836,495 | 746.16M |
| 317 | ETON | Eton Pharmaceuticals, Inc. | 1.45B | -0.55% | 231,002 | 105.60M |
| 318 | GPCR | Structure Therapeutics Inc. | 1.44B | -0.47% | 411,803 | - |
| 319 | KARD | Kardigan, Inc. | 1.43B | 6.84% | 293,946 | - |
| 320 | TSHA | Taysha Gene Therapies, Inc. | 1.41B | 5.62% | 2,106,825 | 5.49M |
| 321 | NUTX | Nutex Health Inc. | 1.41B | 14.32% | 128,336 | 846.72M |
| 322 | ANAB | AnaptysBio, Inc. | 1.40B | -1.82% | 278,288 | 106.09M |
| 323 | URGN | UroGen Pharma Ltd. | 1.40B | -16.83% | 2,376,351 | 250.25M |
| 324 | ENOV | Enovis Corporation | 1.40B | 15.80% | 2,498,350 | 2.30B |
| 325 | DMRA | Damora Therapeutics, Inc. | 1.38B | 1.49% | 427,268 | - |
| 326 | KRSA | Korsana Biosciences, Inc. | 1.38B | -5.01% | 104,434 | - |
| 327 | STAA | STAAR Surgical Company | 1.37B | 8.18% | 583,580 | 339.59M |
| 328 | GHRS | GH Research PLC | 1.36B | -2.12% | 229,256 | - |
| 329 | USPH | U.S. Physical Therapy, Inc. | 1.34B | 5.82% | 154,131 | 804.27M |
| 330 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 7.99% | 2,495,087 | 1.04B |
| 331 | OPK | OPKO Health, Inc. | 1.32B | 2.91% | 2,505,998 | 587.90M |
| 332 | INNV | InnovAge Holding Corp. | 1.32B | 9.38% | 690,460 | 1.02B |
| 333 | OMER | Omeros Corporation | 1.32B | -0.16% | 560,493 | 38.42M |
| 334 | DRTS | Alpha Tau Medical Ltd. | 1.31B | 4.43% | 455,229 | - |
| 335 | CRON | Cronos Group Inc. | 1.30B | 3.99% | 1,809,110 | 179.09M |
| 336 | NKTR | Nektar Therapeutics | 1.30B | 1.03% | 273,037 | 54.59M |
| 337 | LBRX | LB Pharmaceuticals Inc | 1.29B | -0.77% | 246,871 | - |
| 338 | ATEC | Alphatec Holdings, Inc. | 1.29B | 10.98% | 5,072,546 | 839.72M |
| 339 | AORT | Artivion, Inc. | 1.28B | 10.71% | 631,815 | 471.47M |
| 340 | GDRX | GoodRx Holdings, Inc. | 1.27B | 6.88% | 1,419,295 | 785.23M |
| 341 | MNKD | MannKind Corporation | 1.26B | 4.69% | 2,562,405 | 393.63M |
| 342 | PRCT | PROCEPT BioRobotics Corporation | 1.25B | 8.58% | 1,725,806 | 337.34M |
| 343 | LMRI | Lumexa Imaging Holdings, Inc. | 1.25B | 15.86% | 1,126,536 | 1.04B |
| 344 | INBX | Inhibrx Biosciences, Inc. | 1.25B | 4.48% | 131,745 | 1.30M |
| 345 | VOR | Vor Biopharma Inc. | 1.22B | 0.30% | 252,870 | - |
| 346 | FRNM | Freenome, Inc. | 1.21B | -2.22% | 487,581 | 35.41M |
| 347 | OMDA | Omada Health, Inc. | 1.20B | 5.87% | 455,210 | 309.76M |
| 348 | AVLN | Avalyn Pharma Inc. | 1.20B | 0.71% | 163,157 | - |
| 349 | VSTM | Verastem, Inc. | 1.19B | 0.61% | 1,872,415 | 87.53M |
| 350 | SLN | Silence Therapeutics plc | 1.19B | - | 791,271 | 615.00K |
| 351 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.19B | 2.88% | 414,922 | 730.02M |
| 352 | CMPS | COMPASS Pathways plc | 1.18B | -0.47% | 4,202,222 | - |
| 353 | SVRA | Savara Inc. | 1.18B | -2.53% | 2,817,851 | - |
| 354 | AHG | Akso Health Group | 1.17B | 13.22% | 3,930 | 13.83M |
| 355 | SGP | SpyGlass Pharma, Inc. | 1.14B | -0.81% | 160,504 | - |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.14B | 7.56% | 669,883 | 1.66B |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.14B | 4.98% | 193,268 | - |
| 358 | IRMD | IRADIMED CORPORATION | 1.13B | 9.05% | 122,625 | 89.34M |
| 359 | SIBN | SI-BONE, Inc. | 1.11B | 4.50% | 1,674,111 | 220.65M |
| 360 | JANX | Janux Therapeutics, Inc. | 1.11B | 1.82% | 759,868 | 24.00M |
| 361 | CSTL | Castle Biosciences, Inc. | 1.11B | 3.09% | 155,379 | 357.28M |
| 362 | HROW | Harrow, Inc. | 1.08B | 1.05% | 550,132 | 275.59M |
| 363 | CBLL | CeriBell, Inc. | 1.07B | -1.06% | 894,941 | 108.72M |
| 364 | HSTM | HealthStream, Inc. | 994.37M | 2.62% | 157,711 | 327.95M |
| 365 | BVS | Bioventus Inc. | 979.67M | 6.44% | 799,557 | 585.64M |
| 366 | QDEL | QuidelOrtho Corporation | 978.57M | 1.28% | 1,998,253 | 2.59B |
| 367 | AHCO | AdaptHealth Corp. | 977.89M | 16.72% | 4,680,273 | 3.44B |
| 368 | ORIC | ORIC Pharmaceuticals, Inc. | 976.41M | -1.77% | 2,235,242 | - |
| 369 | MLTX | MoonLake Immunotherapeutics | 974.47M | -2.14% | 872,864 | - |
| 370 | RIGL | Rigel Pharmaceuticals, Inc. | 955.48M | 4.69% | 148,221 | 276.79M |
| 371 | IMTX | Immatics N.V. | 954.10M | -1.34% | 421,370 | 47.65M |
| 372 | GMRS | GMR Solutions Inc. | 951.70M | 7.51% | 619,905 | 5.88B |
| 373 | LTGO | Latigo Biotherapeutics, Inc. | 950.73M | -1.58% | 99,428 | - |
| 374 | JBIO | Jade Biosciences, Inc. | 946.97M | 2.20% | 736,387 | - |
| 375 | ODTX | Odyssey Therapeutics, Inc. | 921.47M | -10.85% | 519,767 | 99.00K |
| 376 | GLUE | Monte Rosa Therapeutics, Inc. | 914.56M | 2.98% | 1,117,751 | 28.73M |
| 377 | BBNX | Beta Bionics, Inc. | 914.45M | 11.39% | 683,840 | 127.27M |
| 378 | ANRO | Alto Neuroscience, Inc. | 912.97M | 2.49% | 264,810 | - |
| 379 | IVA | Inventiva S.A. | 911.99M | -2.98% | 1,315,483 | 2.81M |
| 380 | SNDX | Syndax Pharmaceuticals, Inc. | 907.26M | -28.90% | 12,312,291 | 289.68M |
| 381 | MGTX | MeiraGTx Holdings plc | 905.69M | -0.95% | 354,121 | 397.50M |
| 382 | KIDS | OrthoPediatrics Corp. | 887.76M | 8.25% | 386,983 | 264.14M |
| 383 | PRME | Prime Medicine, Inc. | 883.29M | 9.12% | 3,458,371 | 4.07M |
| 384 | CRVS | Corvus Pharmaceuticals, Inc. | 873.60M | 5.65% | 848,722 | - |
| 385 | PHAR | Pharming Group N.V. | 867.86M | -1.43% | 26,738 | 386.75M |
| 386 | CTY | City Therapeutics, Inc. | 864.27M | -9.01% | 266,696 | 14.34M |
| 387 | ALMS | Alumis Inc. | 841.33M | - | 736,904 | 7.40M |
| 388 | AKTS | Aktis Oncology, Inc. | 836.52M | 0.67% | 138,073 | 10.06M |
| 389 | PACB | Pacific Biosciences of California, Inc. | 833.03M | 9.84% | 14,894,066 | 159.27M |
| 390 | ANNX | Annexon, Inc. | 824.67M | 3.82% | 3,465,926 | - |
| 391 | INMD | InMode Ltd. | 823.41M | 1.74% | 539,928 | 374.63M |
| 392 | PHR | Phreesia, Inc. | 821.82M | 8.26% | 395,402 | 507.79M |
| 393 | ARDX | Ardelyx, Inc. | 809.86M | 7.26% | 7,164,346 | 468.22M |
| 394 | BBTX | Bambusa Therapeutics, Inc. | 809.48M | -0.69% | 159,377 | - |
| 395 | ABUS | Arbutus Biopharma Corporation | 797.33M | 3.87% | 1,512,980 | 181.72M |
| 396 | CGEM | Cullinan Therapeutics, Inc. | 782.55M | -22.79% | 1,633,964 | - |
| 397 | VREX | Varex Imaging Corporation | 781.21M | 0.03% | 354,293 | 865.00M |
| 398 | CTKB | Cytek Biosciences, Inc. | 781.20M | 0.84% | 1,018,741 | 206.71M |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 776.13M | 0.46% | 399,929 | 808.21M |
| 400 | SANA | Sana Biotechnology, Inc. | 766.36M | 4.92% | 2,056,608 | - |
| 401 | DNA | Ginkgo Bioworks Holdings, Inc. | 762.97M | 5.30% | 1,754,848 | 132.42M |
| 402 | OABI | OmniAb, Inc. | 748.99M | -0.29% | 765,309 | 40.21M |
| 403 | WVE | Wave Life Sciences, Inc. | 719.89M | 1.96% | 1,807,065 | 70.92M |
| 404 | ACHV | Achieve Life Sciences, Inc. | 719.80M | 3.94% | 902,222 | - |
| 405 | ATTO | Attovia Therapeutics, Inc. | 705.54M | 1.21% | 257,315 | 1.80M |
| 406 | SGMT | Sagimet Biosciences Inc. | 704.83M | -0.10% | 522,535 | - |
| 407 | STLN | Starling Oncology, Inc. | 701.18M | 8.52% | 1,275,189 | 587.24M |
| 408 | SLDB | Solid Biosciences Inc. | 691.60M | 2.71% | 723,102 | - |
| 409 | CADL | Candel Therapeutics, Inc. | 683.31M | 1.25% | 671,525 | - |
| 410 | AURA | Aura Biosciences, Inc. | 682.38M | 5.45% | 694,684 | - |
| 411 | KURA | Kura Oncology, Inc. | 677.88M | -22.87% | 6,299,607 | 77.23M |
| 412 | FDMT | 4D Molecular Therapeutics, Inc. | 676.19M | 2.43% | 555,826 | 92.01M |
| 413 | SLBT | SL Science Holding Limited | 672.91M | -3.28% | 34,880 | 3.27M |
| 414 | LXRX | Lexicon Pharmaceuticals, Inc. | 667.43M | 2.74% | 957,192 | 41.47M |
| 415 | OBX | Obsidian Therapeutics, Inc. | 662.21M | -18.97% | 372,538 | - |
| 416 | GERN | Geron Corporation | 661.75M | 10.75% | 21,647,336 | 217.52M |
| 417 | DSGN | Design Therapeutics, Inc. | 661.49M | 2.22% | 176,299 | - |
| 418 | AVBP | ArriVent BioPharma, Inc. | 661.22M | 3.00% | 902,243 | - |
| 419 | OLMA | Olema Pharmaceuticals, Inc. | 652.73M | 1.50% | 782,814 | - |
| 420 | APMD | Apnimed, Inc. | 652.15M | 4.02% | 485,258 | 115.12M |
| 421 | IMMX | Immix Biopharma, Inc. | 649.13M | 1.56% | 834,662 | - |
| 422 | ZVRA | Zevra Therapeutics, Inc. | 646.69M | 6.14% | 1,469,118 | 147.76M |
| 423 | IAM | Iambic Therapeutics, Inc. | 642.04M | 0.41% | 238,369 | 18.25M |
| 424 | HELP | Helus Pharma Inc. | 632.70M | -4.10% | 881,043 | - |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 622.95M | 7.71% | 1,314,245 | 389.32M |
| 426 | TCMD | Tactile Systems Technology, Inc. | 619.77M | 10.41% | 542,708 | 356.42M |
| 427 | DBVT | DBV Technologies S.A. | 607.84M | -2.27% | 220,292 | 3.74M |
| 428 | ANL | Adlai Nortye Group Ltd. | 597.93M | -3.08% | 97,417 | 18.06M |
| 429 | AVR | Anteris Technologies Global Corp. | 588.37M | 7.77% | 787,055 | 2.24M |
| 430 | NVCT | Nuvectis Pharma, Inc. | 587.77M | -6.72% | 231,641 | - |
| 431 | BCAX | Bicara Therapeutics Inc. | 587.28M | -0.95% | 541,455 | - |
| 432 | CBIO | Crescent Biopharma, Inc. | 583.81M | 4.44% | 73,744 | 11.88M |
| 433 | SOPH | SOPHiA GENETICS SA | 580.57M | -1.30% | 378,104 | 90.97M |
| 434 | MYGN | Myriad Genetics, Inc. | 579.64M | 0.33% | 1,018,620 | 806.60M |
| 435 | DMAC | DiaMedica Therapeutics Inc. | 573.77M | 6.40% | 319,441 | - |
| 436 | EVO | Evotec SE | 570.64M | -0.32% | 52,951 | 819.47M |
| 437 | NRC | NRC Health | 568.95M | 11.38% | 171,760 | 143.79M |
| 438 | ACRS | Aclaris Therapeutics, Inc. | 567.24M | -2.14% | 1,296,022 | 8.22M |
| 439 | VALN | Valneva SE | 566.25M | 5.08% | 5,809 | 163.30M |
| 440 | NGNE | Neurogene Inc. | 558.52M | 4.65% | 108,332 | 925.00K |
| 441 | PBYI | Puma Biotechnology, Inc. | 552.33M | 4.70% | 300,655 | 231.24M |
| 442 | SRZN | Surrozen, Inc. | 550.40M | 4.45% | 164,183 | 11.51M |
| 443 | EVH | Evolent Health, Inc. | 544.95M | 12.09% | 1,531,447 | 2.10B |
| 444 | ENTX | Entera Bio Ltd. | 542.64M | 2.30% | 125,783 | 42.00K |
| 445 | FLGT | Fulgent Genetics, Inc. | 539.30M | 1.19% | 197,769 | 323.93M |
| 446 | SGHT | Sight Sciences, Inc. | 538.76M | 3.82% | 512,218 | 83.38M |
| 447 | CLYM | Climb Bio, Inc. | 533.01M | -4.82% | 563,446 | - |
| 448 | OVID | Ovid Therapeutics Inc. | 523.40M | 11.67% | 1,619,317 | 1.58M |
| 449 | STTK | Shattuck Labs, Inc. | 522.39M | -4.84% | 442,188 | 1.00M |
| 450 | ANGO | AngioDynamics, Inc. | 520.84M | 5.58% | 542,342 | 325.38M |
| 451 | DCTH | Delcath Systems, Inc. | 513.20M | 2.71% | 229,336 | 95.42M |
| 452 | RGNX | REGENXBIO Inc. | 508.96M | 1.05% | 658,459 | 174.48M |
| 453 | FTH | Faeth Therapeutics, Inc. | 505.70M | -0.41% | 168,981 | - |
| 454 | CAPR | Capricor Therapeutics, Inc. | 504.65M | 5.34% | 4,646,467 | 11.13M |
| 455 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 456 | RCEL | AVITA Medical, Inc. | 504.11M | 6.33% | 400,547 | 75.63M |
| 457 | CTMX | CytomX Therapeutics, Inc. | 503.35M | 5.96% | 3,615,269 | 18.30M |
| 458 | INDP | Indaptus Therapeutics, Inc. | 502.21M | 0.93% | 92,065 | - |
| 459 | CERS | Cerus Corporation | 497.77M | 5.56% | 1,702,733 | 226.57M |
| 460 | EOLS | Evolus, Inc. | 495.38M | 1.76% | 421,722 | 316.49M |
| 461 | ETRA | Electra Therapeutics, Inc. | 486.76M | -3.90% | 286,688 | - |
| 462 | AQST | Aquestive Therapeutics, Inc. | 484.47M | -0.52% | 2,458,261 | 48.84M |
| 463 | SENS | Senseonics Holdings, Inc. | 479.30M | 2.31% | 425,150 | 48.55M |
| 464 | YDES | YD Bio Limited | 478.11M | 5.55% | 50,222 | 1.24M |
| 465 | ARVN | Arvinas, Inc. | 476.67M | 2.82% | 863,082 | 275.30M |
| 466 | MNPR | Monopar Therapeutics Inc. | 476.20M | 1.51% | 161,528 | - |
| 467 | GYRE | Gyre Therapeutics, Inc. | 469.73M | -0.23% | 214,306 | 109.82M |
| 468 | MDXG | MiMedx Group, Inc. | 463.31M | -2.31% | 1,182,223 | 303.73M |
| 469 | RLMD | Relmada Therapeutics, Inc. | 459.75M | 0.94% | 1,686,874 | - |
| 470 | NPCE | NeuroPace, Inc. | 459.60M | 8.77% | 146,798 | 106.99M |
| 471 | TKNO | Alpha Teknova, Inc. | 457.83M | 1.09% | 206,195 | 43.70M |
| 472 | SRTA | Strata Critical Medical, Inc. | 457.37M | 16.44% | 2,170,992 | 280.76M |
| 473 | MASS | 908 Devices Inc. | 456.32M | 3.47% | 181,725 | 60.84M |
| 474 | PHAT | Phathom Pharmaceuticals, Inc. | 454.34M | -0.35% | 1,082,833 | 274.88M |
| 475 | BWAY | BrainsWay Ltd. | 451.98M | 0.54% | 74,970 | 60.70M |
| 476 | OCS | Oculis Holding AG | 450.64M | -4.33% | 405,224 | 1.12M |
| 477 | EPRX | Eupraxia Pharmaceuticals Inc. | 446.48M | -1.74% | 453,075 | - |
| 478 | CRMD | CorMedix Inc. | 442.72M | 2.16% | 1,079,122 | 462.25M |
| 479 | SI | Shoulder Innovations, Inc. | 441.15M | 6.91% | 70,710 | 60.06M |
| 480 | SSII | SS Innovations International, Inc. | 440.85M | -5.58% | 26,231 | 52.40M |
| 481 | CARL | Carlsmed, Inc. | 437.66M | 11.32% | 73,996 | 63.30M |
| 482 | PRTA | Prothena Corporation plc | 430.72M | 2.19% | 166,067 | 54.53M |
| 483 | TLRY | Tilray Brands, Inc. | 430.45M | 10.75% | 10,661,939 | 963.10M |
| 484 | RZLT | Rezolute, Inc. | 418.54M | -0.50% | 745,678 | - |
| 485 | PRLD | Prelude Therapeutics Incorporated | 417.13M | 7.14% | 300,609 | 22.42M |
| 486 | EDIT | Editas Medicine, Inc. | 416.97M | 4.42% | 1,808,393 | 47.01M |
| 487 | KMDA | Kamada Ltd. | 413.22M | 1.93% | 94,255 | 191.85M |
| 488 | ALT | Altimmune, Inc. | 412.38M | 3.92% | 2,387,992 | 31.00K |
| 489 | ALLO | Allogene Therapeutics, Inc. | 405.95M | 4.91% | 14,182,507 | 4.64M |
| 490 | ASMB | Assembly Biosciences, Inc. | 401.92M | -0.90% | 158,614 | 74.85M |
| 491 | TECX | Tectonic Therapeutic, Inc. | 391.57M | 5.53% | 154,300 | - |
| 492 | OFIX | Orthofix Medical Inc. | 391.44M | 9.70% | 819,852 | 833.19M |
| 493 | ZURA | Zura Bio Limited | 389.15M | 1.25% | 1,506,665 | - |
| 494 | CCCC | C4 Therapeutics, Inc. | 386.91M | -2.02% | 1,462,218 | 35.04M |
| 495 | VMD | Viemed Healthcare, Inc. | 385.83M | 7.14% | 123,374 | 301.61M |
| 496 | AVTX | Avalo Therapeutics, Inc. | 375.95M | -3.31% | 902,622 | 59.00K |
| 497 | LYEL | Lyell Immunopharma, Inc. | 373.95M | 41.69% | 982,891 | 27.00K |
| 498 | MPLT | MapLight Therapeutics, Inc. | 372.91M | -1.47% | 262,652 | - |
| 499 | BLSM | BlossomHill Therapeutics, Inc. | 370.61M | -6.04% | 224,462 | - |
| 500 | EMBC | Embecta Corp. | 369.42M | 7.24% | 789,551 | 1.02B |